WHO releases Medical Product Alert for contaminated cough syrup

Betsy Goodfellow | July 20, 2023 | News story | Medical Communications Pharmacy, WHO, cough syrups, medical product alert, world health organization 

The World Health Organization (WHO) has shared a Medical Product Alert for an additional contaminated cough syrup medicine identified in Africa.

The product alert refers to a Naturcold syrup identified in Cameroon and first reported to WHO on the 13 March 2023. The active ingredients in the cough syrup are listed as paracetamol, phenylephrine hydrochloride and chlorpheniramine maleate, a combination often used to relieve symptoms of the common cold, flu and allergic rhinitis.

Samples of the Naturcold syrup were provided to WHO on the 27 June 2023, which were assessed in a WHO contracted and prequalified laboratory. This assessment found that the syrup contained unacceptable levels of diethylene glycol as contaminants. The samples contained levels of the contaminant of up to 28.6%, while acceptable levels are no more than 0.10%.

The manufacturer of the product is listed as UK-based, operating under the name Fraken International. However, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed that this company does not exist in the UK, meaning the origin of the product is still unknown. Inquires are underway to determine its origin, however at present the manufacturer has not provided any guarantees to WHO on the safety or quality of the products.

Various other cough syrups have also been identified by WHO as having been contaminated, making this the latest in a line of similar Medical Product Alerts.

Betsy Goodfellow

Related Content

Scientists use AI to find new antibiotic to fight superbug

Scientists at McMaster University and the Massachusetts Institute of Technology (MIT) have utilised artificial intelligence …


Moderna to supply up to 500 million COVID-19 vaccines to COVAX

Moderna have announced a supply agreement with Gavi, the Vaccine Alliance, for up to 500 …


Netherlands suspends AstraZeneca vaccine despite safety assurances

The Netherlands has become the latest country to suspend the use of the Oxford-AstraZeneca vaccine …

Latest content